BASF India is the Indian arm of the global chemicals major, spanning materials, industrial solutions, nutrition and care, chemicals and agricultural solutions — and this quarter's print lands against surging crude-linked feedstock costs and a monsoon that ended at 87% of its long-period average. The key things the results will speak to are whether Q1 FY27's volume-plus-price recovery (revenue up 28.94% YoY) persisted into Q2, and progress on the portfolio overhaul — the BASIL agricultural demerger, the Coatings divestment and the Dahej Care Chemicals closure.
| Results date | November 04, 2026 |
|---|---|
| Quarter | Q2 FY 2026-2027 |
| Previous quarter revenue | Rs. 4,837.44 Cr |
| Previous quarter PAT | Rs. 362.05 Cr |
| Market cap | Rs. 13,193.01 Cr |
| CMP | Rs. 3,049.1 |
As intimated to the exchanges on September 25, 2026, the Board of Directors will meet on November 4, 2026 at 12:30 PM at Godrej One, Vikhroli, to approve the Standalone & Consolidated Unaudited Financial Results for the quarter and half year ending September 30, 2026 (SEBI LODR Regs 29(1)(a) & (e), 33(3)).
Separately, the company has already declared a final dividend of Rs. 25 per share (250%) for FY ended March 31, 2026, approved with 99.99% votes at the 82nd AGM on August 12, 2026. No new dividend specifics for the November 4 meeting have been intimated.
The Q2 FY 2026-2027 print will test whether Q1 FY27's volume-plus-price recovery — standalone revenue of Rs. 4,837.44 Cr, up 28.94% YoY — survived a quarter in which the Indian crude basket climbed from $82.04/bbl in July to $116.09/bbl in September and the monsoon ended at 87% of LPA, the lowest since 2015.
Management had explicitly flagged caution for this half, citing the ongoing Middle East crisis, a delayed monsoon and 'less herbicide sprays because of that in the market', alongside 'a slight softening of demand' in one or the other industry sector. The Agricultural Solutions segment is the most exposed: it was already down 18% YoY in Q1 with margin compressed from 24.40% to 13.91%, and Kharif sowing in rice, maize and cotton — crop-protection-intensive crops — remained lower year-on-year.
Feedstock inflation is the other swing factor, with petrochemical inputs reliant on Strait of Hormuz flows 'most affected' and the rupee weak in the mid-Rs. 95s/USD, though pre-surge inventory of Rs. 2,708.91 Cr on the March 31, 2026 balance sheet may cushion the cost pass-through timing.
On the portfolio side, the BASIL demerger remains on track with NCLT approval guided by end-2026, legal separation effective January 1, 2027 and listing targeted H1 2027, while the Dahej Care Chemicals closure (a Rs. 542 Cr, 4%-of-revenue business) is slated by end of calendar 2026. Management gives no P&L guidance by policy, so the call will focus on timeline commitments, the volume-price split of Q2 revenue, and opex control against the 13.2%-of-revenue level reported in H1 FY26.
Guidance and timeline tracking: Management gives no P&L guidance, so these timeline commitments are the markers to track on the call.
Q2 volume-price split and margin direction: Whether Q1 FY27's recovery persisted into the September quarter despite the macro tape.
Agricultural Solutions and monsoon impact: The segment most exposed to the deficient monsoon and West Asia supply disruptions.
An analyst pointed out EBITDA of Rs. 633 crores in FY21 versus Rs. 656 crores in FY26. Management responded that the two years are not very comparable — the construction chemicals business was sold and FY21 included a COVID rebound — with Chinese oversupply pressuring margins in a tough competitive environment.
Around Rs. 150 Cr had been spent as of the Q4 FY26 call, with an additional Rs. 150–170 Cr required to reach production; the project cost was cited at Rs. 104 Cr in the Q1 FY27 call. The expansion was completed in May 2026 and is expected to go live by end-2026.
Shareholders approved the scheme with a 99.99% majority on June 24, 2026, and NCLT approval is expected by end of 2026. Legal separation takes effect January 1, 2027, with BASIL share allotment by March 2027 and listing on BSE/NSE targeted in H1 2027.
Management has indicated the cash is earmarked for Dahej and Mangalore capex, dividend payments, and cash transfers of the agricultural segment to BASIL effective January 1, 2027. The company remains cash-rich with no debt-raising announcements in the recent window.
Disclaimer: This earnings preview is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.